LUP Statistics
Record
- Title
- Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.
- Type
- Journal Article
- Publ. year
- 2014
- Author/s
- Ahmad Kiadaliri, Aliasghar; Gerdtham, Ulf; Eliasson, Bjorn; Steen Carlsson, Katarina
- Department/s
- Health Economics; EpiHealth: Epidemiology for Health
- In LUP since
- 2016-04-01
Downloads
| Total | This Year | This Month |
| 350 | 2 | 0 |
United States of America  |
195 (56%) |
Germany  |
69 (20%) |
Russian Federation  |
18 (5%) |
China  |
17 (5%) |
France  |
14 (4%) |
United Kingdom of Great Britain and Northern Ireland  |
5 (1%) |
Sweden  |
5 (1%) |
Singapore  |
5 (1%) |
Ukraine  |
3 (1%) |
Denmark  |
3 (1%) |
Netherlands (Kingdom of the)  |
2 (1%) |
Ireland  |
2 (1%) |
India  |
2 (1%) |
Mexico  |
1 (0%) |
Hungary  |
1 (0%) |
Australia  |
1 (0%) |
Spain  |
1 (0%) |
Romania  |
1 (0%) |
Senegal  |
1 (0%) |
Unknown  |
1 (0%) |
Chile  |
1 (0%) |
Hong Kong (China)  |
1 (0%) |
Canada  |
1 (0%) |